Acton, Richard J.
Yuan, Wei
Gao, Fei http://orcid.org/0000-0002-8026-879X
Xia, Yudong
Bourne, Emma
Wozniak, Eva
Bell, Jordana http://orcid.org/0000-0002-3858-5986
Lillycrop, Karen
Wang, Jun
Dennison, Elaine
Harvey, Nicholas C. http://orcid.org/0000-0002-8194-2512
Mein, Charles A.
Spector, Tim D. http://orcid.org/0000-0002-9795-0365
Hysi, Pirro G. http://orcid.org/0000-0001-5752-2510
Cooper, Cyrus http://orcid.org/0000-0003-3510-0709
Bell, Christopher G. http://orcid.org/0000-0003-4601-1242
Article History
Received: 13 December 2019
Accepted: 5 March 2021
First Online: 11 May 2021
Competing interests
: C.C. has received lecture fees and honoraria from Amgen, Danone, Eli Lilly, GSK, Kyowa Kirin, Medtronic, Merck, Nestle, Novartis, Pfizer, Roche, Servier, Shire, Takeda and UCB outside of the submitted work. N.C.H. reports personal fees, consultancy, lecture fees and honoraria from Alliance for Better Bone Health, AMGEN, MSD, Eli Lilly, Servier, Shire, UCB, Consilient Healthcare, Kyowa Kirin and Internis Pharma, outside the submitted work. E.D. has received speaker/consultancy fees from Pfizer, UCB and Lilly. T.D.S. is a consultant to Zoe Global Ltd (‘Zoe’). All other authors declare no competing interests.